2023-05-012024-09-302024-09-30falseSC627029Stuart Studios (Health) Ltd2025-01-2096040falseiso4217:GBPxbrli:pureSC6270292023-05-01SC6270292024-09-30SC6270292023-05-012024-09-30SC6270292022-05-01SC6270292023-04-30SC6270292022-05-012023-04-30SC627029bus:SmallEntities2023-05-012024-09-30SC627029bus:AuditExempt-NoAccountantsReport2023-05-012024-09-30SC627029bus:FullAccounts2023-05-012024-09-30SC627029bus:PrivateLimitedCompanyLtd2023-05-012024-09-30SC627029core:WithinOneYear2024-09-30SC627029core:AfterOneYear2024-09-30SC627029core:WithinOneYear2023-04-30SC627029core:AfterOneYear2023-04-30SC627029core:ShareCapital2024-09-30SC627029core:SharePremium2024-09-30SC627029core:RevaluationReserve2024-09-30SC627029core:OtherReservesSubtotal2024-09-30SC627029core:RetainedEarningsAccumulatedLosses2024-09-30SC627029core:ShareCapital2023-04-30SC627029core:SharePremium2023-04-30SC627029core:RevaluationReserve2023-04-30SC627029core:OtherReservesSubtotal2023-04-30SC627029core:RetainedEarningsAccumulatedLosses2023-04-30SC627029core:LandBuildings2024-09-30SC627029core:PlantMachinery2024-09-30SC627029core:Vehicles2024-09-30SC627029core:FurnitureFittings2024-09-30SC627029core:OfficeEquipment2024-09-30SC627029core:NetGoodwill2024-09-30SC627029core:IntangibleAssetsOtherThanGoodwill2024-09-30SC627029core:ListedExchangeTraded2024-09-30SC627029core:UnlistedNon-exchangeTraded2024-09-30SC627029core:LandBuildings2023-04-30SC627029core:PlantMachinery2023-04-30SC627029core:Vehicles2023-04-30SC627029core:FurnitureFittings2023-04-30SC627029core:OfficeEquipment2023-04-30SC627029core:NetGoodwill2023-04-30SC627029core:IntangibleAssetsOtherThanGoodwill2023-04-30SC627029core:ListedExchangeTraded2023-04-30SC627029core:UnlistedNon-exchangeTraded2023-04-30SC627029core:LandBuildings2023-05-012024-09-30SC627029core:PlantMachinery2023-05-012024-09-30SC627029core:Vehicles2023-05-012024-09-30SC627029core:FurnitureFittings2023-05-012024-09-30SC627029core:OfficeEquipment2023-05-012024-09-30SC627029core:NetGoodwill2023-05-012024-09-30SC627029core:IntangibleAssetsOtherThanGoodwill2023-05-012024-09-30SC627029core:ListedExchangeTraded2023-05-012024-09-30SC627029core:UnlistedNon-exchangeTraded2023-05-012024-09-30SC627029core:MoreThanFiveYears2023-05-012024-09-30SC627029core:Non-currentFinancialInstruments2024-09-30SC627029core:Non-currentFinancialInstruments2023-04-30SC627029dpl:CostSales2023-05-012024-09-30SC627029dpl:DistributionCosts2023-05-012024-09-30SC627029core:LandBuildings2023-05-012024-09-30SC627029core:PlantMachinery2023-05-012024-09-30SC627029core:Vehicles2023-05-012024-09-30SC627029core:FurnitureFittings2023-05-012024-09-30SC627029core:OfficeEquipment2023-05-012024-09-30SC627029dpl:AdministrativeExpenses2023-05-012024-09-30SC627029core:NetGoodwill2023-05-012024-09-30SC627029core:IntangibleAssetsOtherThanGoodwill2023-05-012024-09-30SC627029dpl:GroupUndertakings2023-05-012024-09-30SC627029dpl:ParticipatingInterests2023-05-012024-09-30SC627029dpl:GroupUndertakingscore:ListedExchangeTraded2023-05-012024-09-30SC627029core:ListedExchangeTraded2023-05-012024-09-30SC627029dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-05-012024-09-30SC627029core:UnlistedNon-exchangeTraded2023-05-012024-09-30SC627029dpl:CostSales2022-05-012023-04-30SC627029dpl:DistributionCosts2022-05-012023-04-30SC627029core:LandBuildings2022-05-012023-04-30SC627029core:PlantMachinery2022-05-012023-04-30SC627029core:Vehicles2022-05-012023-04-30SC627029core:FurnitureFittings2022-05-012023-04-30SC627029core:OfficeEquipment2022-05-012023-04-30SC627029dpl:AdministrativeExpenses2022-05-012023-04-30SC627029core:NetGoodwill2022-05-012023-04-30SC627029core:IntangibleAssetsOtherThanGoodwill2022-05-012023-04-30SC627029dpl:GroupUndertakings2022-05-012023-04-30SC627029dpl:ParticipatingInterests2022-05-012023-04-30SC627029dpl:GroupUndertakingscore:ListedExchangeTraded2022-05-012023-04-30SC627029core:ListedExchangeTraded2022-05-012023-04-30SC627029dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-05-012023-04-30SC627029core:UnlistedNon-exchangeTraded2022-05-012023-04-30SC627029core:NetGoodwill2024-09-30SC627029core:IntangibleAssetsOtherThanGoodwill2024-09-30SC627029core:LandBuildings2024-09-30SC627029core:PlantMachinery2024-09-30SC627029core:Vehicles2024-09-30SC627029core:FurnitureFittings2024-09-30SC627029core:OfficeEquipment2024-09-30SC627029core:AfterOneYear2024-09-30SC627029core:WithinOneYear2024-09-30SC627029core:ListedExchangeTraded2024-09-30SC627029core:UnlistedNon-exchangeTraded2024-09-30SC627029core:ShareCapital2024-09-30SC627029core:SharePremium2024-09-30SC627029core:RevaluationReserve2024-09-30SC627029core:OtherReservesSubtotal2024-09-30SC627029core:RetainedEarningsAccumulatedLosses2024-09-30SC627029core:NetGoodwill2023-04-30SC627029core:IntangibleAssetsOtherThanGoodwill2023-04-30SC627029core:LandBuildings2023-04-30SC627029core:PlantMachinery2023-04-30SC627029core:Vehicles2023-04-30SC627029core:FurnitureFittings2023-04-30SC627029core:OfficeEquipment2023-04-30SC627029core:AfterOneYear2023-04-30SC627029core:WithinOneYear2023-04-30SC627029core:ListedExchangeTraded2023-04-30SC627029core:UnlistedNon-exchangeTraded2023-04-30SC627029core:ShareCapital2023-04-30SC627029core:SharePremium2023-04-30SC627029core:RevaluationReserve2023-04-30SC627029core:OtherReservesSubtotal2023-04-30SC627029core:RetainedEarningsAccumulatedLosses2023-04-30SC627029core:NetGoodwill2022-05-01SC627029core:IntangibleAssetsOtherThanGoodwill2022-05-01SC627029core:LandBuildings2022-05-01SC627029core:PlantMachinery2022-05-01SC627029core:Vehicles2022-05-01SC627029core:FurnitureFittings2022-05-01SC627029core:OfficeEquipment2022-05-01SC627029core:AfterOneYear2022-05-01SC627029core:WithinOneYear2022-05-01SC627029core:ListedExchangeTraded2022-05-01SC627029core:UnlistedNon-exchangeTraded2022-05-01SC627029core:ShareCapital2022-05-01SC627029core:SharePremium2022-05-01SC627029core:RevaluationReserve2022-05-01SC627029core:OtherReservesSubtotal2022-05-01SC627029core:RetainedEarningsAccumulatedLosses2022-05-01SC627029core:AfterOneYear2023-05-012024-09-30SC627029core:WithinOneYear2023-05-012024-09-30SC627029core:Non-currentFinancialInstrumentscore:CostValuation2023-05-012024-09-30SC627029core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-05-012024-09-30SC627029core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-05-012024-09-30SC627029core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-05-012024-09-30SC627029core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-05-012024-09-30SC627029core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-05-012024-09-30SC627029core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-05-012024-09-30SC627029core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-05-012024-09-30SC627029core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-05-012024-09-30SC627029core:Non-currentFinancialInstrumentscore:CostValuation2024-09-30SC627029core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-30SC627029core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-30SC627029core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-30SC627029core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-30SC627029core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-30SC627029core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-30SC627029core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-30SC627029core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-30SC627029core:Non-currentFinancialInstrumentscore:CostValuation2023-04-30SC627029core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-30SC627029core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-30SC627029core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-30SC627029core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-30SC627029core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-30SC627029core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-30SC627029core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-30SC627029core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-30SC627029bus:Director12023-05-012024-09-30

Stuart Studios (Health) Ltd

Registered Number
SC627029
(Scotland)

Unaudited Financial Statements for the Period ended
30 September 2024

Stuart Studios (Health) Ltd
Company Information
for the period from 1 May 2023 to 30 September 2024

Director

Heather Christine Stuart

Registered Address

11 Muirfield Street
Kirkcaldy
KY2 6SY

Registered Number

SC627029 (Scotland)
Stuart Studios (Health) Ltd
Balance Sheet as at
30 September 2024

Notes

30 Sep 2024

30 Apr 2023

£

£

£

£

Current assets
Debtors3504134
504134
Creditors amounts falling due within one year4(21,498)(14,203)
Net current assets (liabilities)(20,994)(14,069)
Total assets less current liabilities(20,994)(14,069)
Net assets(20,994)(14,069)
Capital and reserves
Called up share capital11
Profit and loss account(20,995)(14,070)
Shareholders' funds(20,994)(14,069)
The financial statements were approved and authorised for issue by the Director on 20 January 2025, and are signed on its behalf by:
Heather Christine Stuart
Director
Registered Company No. SC627029
Stuart Studios (Health) Ltd
Notes to the Financial Statements
for the period ended 30 September 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Going concern
The financial statements have been prepared on the going concern basis. The director finds it appropriate for the financial statements to be prepared on this basis despite the net liability position of the company. The company is reliant upon the continued support of the director who has confirmed that she will continue to support the company as required.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Stocks and work in progress
Stock and work in progress are valued at the lower of cost and net realisable value.
2.Average number of employees

20242023
Average number of employees during the year11
3.Debtors: amounts due within one year

2024

2023

££
Other debtors504134
Total504134
4.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables1,4157,019
Bank borrowings and overdrafts868896
Other creditors19,2156,288
Total21,49814,203